A Consensus-Based Treatment Algorithm for Alopecia Areata in Adolescents and Adults: Integrating Severity, Quality of Life, and Disease Dynamics

The document presents a consensus-based treatment algorithm for alopecia areata (AA) in adolescents and adults, emphasizing the integration of disease severity, quality of life, and disease dynamics. Developed by expert dermatologists using a modified Delphi method, the algorithm aims to provide personalized and safe care for AA patients. It expands the definition of disease severity beyond the Severity of Alopecia Tool (SALT) scores to include quality-of-life impact and disease progression rate. Recent therapeutic advances, such as the approval of ritlecitinib for individuals aged 12 and older and baricitinib for adults, have improved treatment options. However, concerns about the long-term safety, access, and personalization of these therapies remain. Future efforts should focus on validating and refining the algorithm in real-world settings and ensuring equitable access to treatment.